You have searched for "2 Million Patient"
Showing 1-10 of 15
Melasma is a skin pigment condition caused mainly by overexposure to sunlight. It can be unsightly, but there are ways to manage it.
WASHINGTON (Reuters) - The World Health Organization, governments and nonprofit groups are saving lives by distributing drugs to developing countries, but they are not paying enough attention to the dangers of drug-resistant bugs, according to a report released on Tuesday.
Doctors hope IBM's Watson supercomputer can help them outsmart cancer.
LONDON: Injecting Roche's cancer drug Avastin as a cheap eye treatment does not appear to increase deaths or serious side effects, according to an independent study that is likely to fuel a row over the medicine's unapproved use.
A landmark medical trial involving Alphabet Inc’s DeepMind artificial intelligence division violated British data protection laws, the UK’s top privacy watchdog ruled.
Deepmind, the digital brain foundry owned by Google's parent company, Alphabet, wants to use artificial intelligence to solve, well, everything. Last year, its software taught itself to play the strategy game Go better than any human on the planet. For its next trick, it wants to move beyond games to a very real-world problem: health care.
Healthcare analytics have the potential to reduce costs of treatment, avoid preventable diseases and improve quality of patient care.
DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc, plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.